Liangke Zhang
- Biomedical Engineering top 5%
- Biomaterials top 2%
- Molecular Biology
- Pharmaceutical Science top 1%
- Materials Chemistry
- Topics
- Nanoparticle-Based Drug Delivery (17 papers)Nanoplatforms for cancer theranostics (17 papers)Pharmacological Effects of Natural Compounds (9 papers)
- Partner nations
- ChinaUnited StatesSouth Korea
In The Last Decade
Liangke Zhang
59 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 111
- Biomedical Engineering 601
- Biomaterials 563
- Molecular Biology 502
- Pharmaceutical Science 351
- Materials Chemistry 243
Countries citing papers authored by Liangke Zhang
This map shows the geographic impact of Liangke Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Liangke Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Liangke Zhang more than expected).
Fields of papers citing papers by Liangke Zhang
This network shows the impact of papers produced by Liangke Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Liangke Zhang. The network helps show where Liangke Zhang may publish in the future.
Co-authorship network of co-authors of Liangke Zhang
This figure shows the co-authorship network connecting the top 25 collaborators of Liangke Zhang. A scholar is included among the top collaborators of Liangke Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Liangke Zhang. Liangke Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 2 | |
| 3 | 1 | |
| 4 | 6 | |
| 5 | 23 | |
| 6 | 51 | |
| 7 | 44 | |
| 8 | 30 | |
| 9 | 37 | |
| 10 | 95 | |
| 11 | 103 | |
| 12 | 23 | |
| 13 | 82 | |
| 14 | 92 | |
| 15 | 42 | |
| 16 | 16 | |
| 17 | 20 | |
| 18 | 77 | |
| 19 | 33 | |
| 20 | 105 |
About Liangke Zhang
Liangke Zhang is a scholar working on Pharmaceutical Science, Molecular Medicine and Biomaterials, having authored 59 papers that have together received 1.8k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (17 papers), Nanoplatforms for cancer theranostics (17 papers) and Pharmacological Effects of Natural Compounds (9 papers). The work is most often cited by research in Pharmaceutical Science (351 citations), Biomaterials (563 citations) and Molecular Medicine (148 citations). Liangke Zhang has collaborated with scholars based in China, United States and South Korea. Frequent co-authors include Wenjing Hu, Huali Chen, Yuntao Jia, Jingyuan Wan, Rui Tian, Pei Yuan, Yan Bai, Pan Li, Zhigang Wang and Yongjiu Lv. Their work appears in journals such as Biomaterials, Advanced Functional Materials and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.